Patients taking escitalopram demonstrated significantly greater improvement in depression symptoms (as measured by the MADRS scale) at weeks 1,2, 4 and 8 with the mean treatment difference at
The trial will be conducted in compliance with the approved FDA protocol and is designed to evaluate the safety and tolerability of the company’s SMaRT Replacement Therapy in
ProGenetics will receive a non-exclusive license to GTC’s patent in the US for the transgenic expression of therapeutic proteins in milk to enable the commercial development of these
The Classic II trial was designed to enroll 109 patients at 20 sites in the US. Patients receive an induction cycle of intravenous clofarabine (Clolar) administered as 30mg/m2
The products are designed to deliver two Anti-Retroviral (ARV) drugs together in recommended strengths and simplify delivery of a more accurate treatment to children in resource poor settings.
The acute mononucleosis study at the University of Minnesota will mark the first of several planned studies of valomaciclovir against Epstein-Barr virus (EBV) related diseases. Fred Volinsky, CEO
Glenmark licensed crofelemer for the indications of acute infectious diarrhea, chronic diarrhea in persons living with HIV/AIDS and pediatric diarrhea in over 140 emerging economies and developing countries.
In accordance with the European Patent Convention, this patent will be granted in a total of 31 European countries of which patents for the remaining 30 countries will
Data from two Phase III, multi-center, randomized, double-blind, 6-week, active-controlled studies of similar design (Ascend I&II) were combined and analyzed. The aim of this analysis was to evaluate
Millipore expects the new facility will employ 120 before the end of 2009. The company currently employs over 1,000 in Massachusetts and almost 6,000 around the world. Millipore’s
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.